Search Results - L Catalano

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma by C. Cerchione, L. Catalano, D. Nappi, G. Musuraca, A. Lucchesi, S. Ronconi, F. Pane, G. Martinelli

    Published in Hematology, Transfusion and Cell Therapy (2020-10-01)
    Get full text
    Article


  2. 2

    Structural and mutational analyses of the Leptospira interrogans virulence-related heme oxygenase provide insights into its catalytic mechanism. by Anabel Soldano, Sebastián Klinke, Lisandro H Otero, Mario Rivera, Daniela L Catalano-Dupuy, Eduardo A Ceccarelli

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  3. 3

    PB1985: CHEMO OR CHEMO-FREE REGIMENS IN HEAVILY PRETREATED MULTIPLE MYELOMA? ROLE OF BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN NOVEL AGENTS’ ERA by C. Cerchione, D. Nappi, A. E. Pareto, S. Ronconi, D. Cangini, M. Ceccolini, G. Musuraca, L. Catalano, G. Martinelli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    PB1986: ADDITION OF CARFILZOMIB AS A THIRD AGENT IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SWITCHING FROM DOUBLET TO TRIPLET by C. Cerchione, D. Nappi, A. E. Pareto, S. Ronconi, D. Cangini, M. Ceccolini, G. Musuraca, L. Catalano, G. Martinelli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    PB2262: PEGFILGRASTIM IN THE SUPPORTIVE CARE OF HEAVILY PRETREATED MULTIPLE MYELOMA IN POMALIDOMIDE-BASED TREATMENT by C. Cerchione, D. Nappi, A. E. Pareto, S. Ronconi, D. Cangini, M. Ceccolini, G. Musuraca, L. Catalano, G. Martinelli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    PB1987: DOMESTIC OPPORTUNITY IN HEAVILY PRETREATED MULTIPLE MYELOMA NOT ELIGIBLE TO HOSPITAL-BASED TREATMENT: ROLE OF POMALIDOMIDE-DEXAMETHASONE by C. Cerchione, D. Nappi, A. E. Pareto, S. Ronconi, D. Cangini, M. Ceccolini, G. Musuraca, L. Catalano, G. Martinelli

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    Variability in response to theta burst TMS for PTSD: The role of epigenetic mediation by John E McGeary, McKenzie J Quinn, Caitlyn N Starr, Matthew Borgia, Chelsie E Benca-Bachman, Jamie L Catalano, Noah S Philip

    Published in Brain Stimulation (2022-05-01)
    Get full text
    Article


  8. 8

    P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA by R Iula, F Trastulli, R Della Pepa, A D’Ambrosio, M Romano, A Leone, G Gaeta, S Palmieri, S Rocco, F Pane, F Ferrara, L Catalano

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  9. 9

    Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial by John E McGeary, Leslie Brick, Noah S Philip, Jonathan Jampel, McKenzie J Quinn, Jamie L Catalano, Chelsie B Benca-Bachman, Robert M Swift

    Published in BMJ Open (2023-01-01)
    Get full text
    Article


Search Tools: